The growth of the global Hemostasis Analyzer Market is largely driven by the technological advancements in coagulation analyzers, increasing prevalence of cardiovascular diseases and blood disorders and the rising geriatric population. Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years.
According to the new market research report Coagulation Analyzer Market is projected to reach $5.0 billion by 2025, at a CAGR of 5.7% between 2020 and 2025.
In 2019, the clinical laboratory analyzers segment accounted for a larger share of the market. Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. The large share of this segment can be attributed to factors such as the growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities.
Siemens Healthineers (Germany), Thermo Fisher Scientific (US), Sysmex Corporation (Japan), Roche Diagnostics (Switzerland), Alere, Inc. (US), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (US), and Horiba Medical (Japan) are some of the key players operating in this Coagulation Analyzer Market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392